Ridge Biotechnologies
Ridge Biotechnologies is a pioneering company in enzyme and targeted drug design, focused on advancing the next generation of precision medicines. Based in Palo Alto, Ridge Bio leverages proprietary machine learning models and extensive cell-free experimentation to develop modular systems that enhance drug stability, manufacturability, and therapeutic performance. The company specializes in creating enzyme-based therapies and bioconjugates, including antibody-drug conjugates and conditionally active prodrugs, which aim to improve precision targeting and reduce off-target toxicities.
Leadership & Board
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $25M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $25M
- Latest Funding Round
- Seed Round
- Post-Money Valuation
- ―
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 09, 2025 | Seed Round | $25.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Sutter Hill Ventures | Seed Round |
| Overlap Holdings | Seed Round |
Similar Companies
A snapshot of private companies similar to Ridge Biotechnologies, helping you discover and navigate related company profiles.
